世界のゴーシェ病治療薬市場予測 2021年-2026年

【英語タイトル】Global Gaucher Disease Drugs Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9538)・商品コード:LPI21MY9538
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:136
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「ゴーシェ病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬など、用途別には、I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病などにセグメント区分してまとめました。ゴーシェ病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ゴーシェ病治療薬の世界市場概要(サマリー)
・ゴーシェ病治療薬の企業別販売量・売上
・ゴーシェ病治療薬の企業別市場シェア
・ゴーシェ病治療薬の世界市場規模 2016年-2021年:種類別(酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬)
・ゴーシェ病治療薬の世界市場規模 2016年-2021年:用途別(I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病)
・ゴーシェ病治療薬の南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・ゴーシェ病治療薬のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ゴーシェ病治療薬のヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ゴーシェ病治療薬の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ゴーシェ病治療薬市場の成長要因・課題・動向
・ゴーシェ病治療薬の世界市場予測 2021年-2026年
・ゴーシェ病治療薬の南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・ゴーシェ病治療薬のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ゴーシェ病治療薬のヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ゴーシェ病治療薬の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ゴーシェ病治療薬の世界市場予測:種類別(酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬)
・ゴーシェ病治療薬の世界市場予測:用途別(I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Gaucher Disease Drugs will have significant change from previous year. By the most conservative estimates of global Gaucher Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1292.3 million in 2019. Over the next five years the Gaucher Disease Drugs market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 1326.1 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Gaucher Disease Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Replace Enzymes
Glucosylceramide Synthase Inhibitors
Osteoporosis Drugs

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Type I Gaucher Disease
Type II Gaucher Disease
Type III Gaucher Disease

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Dong-A-Socio Holdings
Genzyme Corporation
ExSAR Corporation
Neuraltus Pharmaceuticals
Amicus Therapeutics
JCR Pharmaceuticals
Lixte Biotechnology Holdings
Protalix BioTherapeutics
Greenovation Biotech

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Gaucher Disease Drugs Consumption 2016-2026
2.1.2 Gaucher Disease Drugs Consumption CAGR by Region
2.2 Gaucher Disease Drugs Segment by Type
2.2.1 Replace Enzymes
2.2.2 Glucosylceramide Synthase Inhibitors
2.2.3 Osteoporosis Drugs
2.3 Gaucher Disease Drugs Sales by Type
2.3.1 Global Gaucher Disease Drugs Sales Market Share by Type (2016-2021)
2.3.2 Global Gaucher Disease Drugs Revenue and Market Share by Type (2016-2021)
2.3.3 Global Gaucher Disease Drugs Sale Price by Type (2016-2021)
2.4 Gaucher Disease Drugs Segment by Application
2.4.1 Type I Gaucher Disease
2.4.2 Type II Gaucher Disease
2.4.3 Type III Gaucher Disease
2.5 Gaucher Disease Drugs Sales by Application
2.5.1 Global Gaucher Disease Drugs Sale Market Share by Application (2016-2021)
2.5.2 Global Gaucher Disease Drugs Revenue and Market Share by Application (2016-2021)
2.5.3 Global Gaucher Disease Drugs Sale Price by Application (2016-2021)

3 Global Gaucher Disease Drugs by Company
3.1 Global Gaucher Disease Drugs Sales Market Share by Company
3.1.1 Global Gaucher Disease Drugs Sales by Company (2019-2021)
3.1.2 Global Gaucher Disease Drugs Sales Market Share by Company (2019-2021)
3.2 Global Gaucher Disease Drugs Revenue Market Share by Company
3.2.1 Global Gaucher Disease Drugs Revenue by Company (2019-2021)
3.2.2 Global Gaucher Disease Drugs Revenue Market Share by Company (2019-2021)
3.3 Global Gaucher Disease Drugs Sale Price by Company
3.4 Global Manufacturers Gaucher Disease Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gaucher Disease Drugs Product Location Distribution
3.4.2 Players Gaucher Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Gaucher Disease Drugs by Region
4.1 Global Gaucher Disease Drugs by Region
4.1.1 Global Gaucher Disease Drugs Sales by Region
4.1.2 Global Gaucher Disease Drugs Revenue by Region
4.2 Americas Gaucher Disease Drugs Sales Growth
4.3 APAC Gaucher Disease Drugs Sales Growth
4.4 Europe Gaucher Disease Drugs Sales Growth
4.5 Middle East & Africa Gaucher Disease Drugs Sales Growth

5 Americas
5.1 Americas Gaucher Disease Drugs Sales by Country
5.1.1 Americas Gaucher Disease Drugs Sales by Country (2016-2021)
5.1.2 Americas Gaucher Disease Drugs Revenue by Country (2016-2021)
5.2 Americas Gaucher Disease Drugs Sales by Type
5.3 Americas Gaucher Disease Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Gaucher Disease Drugs Sales by Region
6.1.1 APAC Gaucher Disease Drugs Sales by Region (2016-2021)
6.1.2 APAC Gaucher Disease Drugs Revenue by Region (2016-2021)
6.2 APAC Gaucher Disease Drugs Sales by Type
6.3 APAC Gaucher Disease Drugs Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Gaucher Disease Drugs by Country
7.1.1 Europe Gaucher Disease Drugs Sales by Country (2016-2021)
7.1.2 Europe Gaucher Disease Drugs Revenue by Country (2016-2021)
7.2 Europe Gaucher Disease Drugs Sales by Type
7.3 Europe Gaucher Disease Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Gaucher Disease Drugs by Country
8.1.1 Middle East & Africa Gaucher Disease Drugs Sales by Country (2016-2021)
8.1.2 Middle East & Africa Gaucher Disease Drugs Revenue by Country (2016-2021)
8.2 Middle East & Africa Gaucher Disease Drugs Sales by Type
8.3 Middle East & Africa Gaucher Disease Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Gaucher Disease Drugs Distributors
10.3 Gaucher Disease Drugs Customer

11 Global Gaucher Disease Drugs Market Forecast
11.1 Global Gaucher Disease Drugs Forecast by Region
11.1.1 Global Gaucher Disease Drugs Forecast by Regions (2021-2026)
11.2.2 Global Gaucher Disease Drugs Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Gaucher Disease Drugs Forecast by Type
11.7 Global Gaucher Disease Drugs Forecast by Application

12 Key Players Analysis
12.1 Dong-A-Socio Holdings
12.1.1 Dong-A-Socio Holdings Dong-A-Socio Holdings Company Information
12.1.2 Dong-A-Socio Holdings Gaucher Disease Drugs Product Offered
12.1.3 Dong-A-Socio Holdings Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Dong-A-Socio Holdings Main Business Overview
12.1.5 Dong-A-Socio Holdings Latest Developments
12.2 Genzyme Corporation
12.2.1 Genzyme Corporation Company Information
12.2.2 Genzyme Corporation Gaucher Disease Drugs Product Offered
12.2.3 Genzyme Corporation Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Genzyme Corporation Main Business Overview
12.2.5 Genzyme Corporation Latest Developments
12.3 ExSAR Corporation
12.3.1 ExSAR Corporation Company Information
12.3.2 ExSAR Corporation Gaucher Disease Drugs Product Offered
12.3.3 ExSAR Corporation Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 ExSAR Corporation Main Business Overview
12.3.5 ExSAR Corporation Latest Developments
12.4 Neuraltus Pharmaceuticals
12.4.1 Neuraltus Pharmaceuticals Company Information
12.4.2 Neuraltus Pharmaceuticals Gaucher Disease Drugs Product Offered
12.4.3 Neuraltus Pharmaceuticals Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Neuraltus Pharmaceuticals Main Business Overview
12.4.5 Neuraltus Pharmaceuticals Latest Developments
12.5 Amicus Therapeutics
12.5.1 Amicus Therapeutics Company Information
12.5.2 Amicus Therapeutics Gaucher Disease Drugs Product Offered
12.5.3 Amicus Therapeutics Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Amicus Therapeutics Main Business Overview
12.5.5 Amicus Therapeutics Latest Developments
12.6 JCR Pharmaceuticals
12.6.1 JCR Pharmaceuticals Company Information
12.6.2 JCR Pharmaceuticals Gaucher Disease Drugs Product Offered
12.6.3 JCR Pharmaceuticals Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 JCR Pharmaceuticals Main Business Overview
12.6.5 JCR Pharmaceuticals Latest Developments
12.7 Lixte Biotechnology Holdings
12.7.1 Lixte Biotechnology Holdings Company Information
12.7.2 Lixte Biotechnology Holdings Gaucher Disease Drugs Product Offered
12.7.3 Lixte Biotechnology Holdings Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Lixte Biotechnology Holdings Main Business Overview
12.7.5 Lixte Biotechnology Holdings Latest Developments
12.8 Protalix BioTherapeutics
12.8.1 Protalix BioTherapeutics Company Information
12.8.2 Protalix BioTherapeutics Gaucher Disease Drugs Product Offered
12.8.3 Protalix BioTherapeutics Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Protalix BioTherapeutics Main Business Overview
12.8.5 Protalix BioTherapeutics Latest Developments
12.9 Greenovation Biotech
12.9.1 Greenovation Biotech Company Information
12.9.2 Greenovation Biotech Gaucher Disease Drugs Product Offered
12.9.3 Greenovation Biotech Gaucher Disease Drugs Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Greenovation Biotech Main Business Overview
12.9.5 Greenovation Biotech Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Gaucher Disease Drugs Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Replace Enzymes
Table 3. Major Players of Glucosylceramide Synthase Inhibitors
Table 4. Major Players of Osteoporosis Drugs
Table 5. Global Gaucher Disease Drugs Sales by Type (2016-2021) & (K Units)
Table 6. Global Gaucher Disease Drugs Sales Market Share by Type (2016-2021)
Table 7. Global Gaucher Disease Drugs Revenue by Type (2016-2021) & ($ million)
Table 8. Global Gaucher Disease Drugs Revenue Market Share by Type (2016-2021)
Table 9. Global Gaucher Disease Drugs Sale Price by Type (2016-2021)
Table 10. Global Gaucher Disease Drugs Sales by Application (2016-2021) & (K Units)
Table 11. Global Gaucher Disease Drugs Sales Market Share by Application (2016-2021)
Table 12. Global Gaucher Disease Drugs Value by Application (2016-2021)
Table 13. Global Gaucher Disease Drugs Revenue Market Share by Application (2016-2021)
Table 14. Global Gaucher Disease Drugs Sale Price by Application (2016-2021)
Table 15. Global Gaucher Disease Drugs Sales by Company (2019-2021) & (K Units)
Table 16. Global Gaucher Disease Drugs Sales Market Share by Company (2019-2021)
Table 17. Global Gaucher Disease Drugs Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Gaucher Disease Drugs Revenue Market Share by Company (2019-2021)
Table 19. Global Gaucher Disease Drugs Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Gaucher Disease Drugs Producing Area Distribution and Sales Area
Table 21. Players Gaucher Disease Drugs Products Offered
Table 22. Gaucher Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Gaucher Disease Drugs Sales by Region (2016-2021) (K Units)
Table 26. Global Gaucher Disease Drugs Sales Market Share by Region (2016-2021)
Table 27. Global Gaucher Disease Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Gaucher Disease Drugs Revenue Market Share by Region (2016-2021)
Table 29. Americas Gaucher Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 30. Americas Gaucher Disease Drugs Sales Market Share by Country (2016-2021)
Table 31. Americas Gaucher Disease Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Gaucher Disease Drugs Revenue Market Share by Country (2016-2021)
Table 33. Americas Gaucher Disease Drugs Sales by Type (2016-2021) & (K Units)
Table 34. Americas Gaucher Disease Drugs Sales Market Share by Type (2016-2021)
Table 35. Americas Gaucher Disease Drugs Sales by Application (2016-2021) & (K Units)
Table 36. Americas Gaucher Disease Drugs Sales Market Share by Application (2016-2021)
Table 37. APAC Gaucher Disease Drugs Sales by Region (2016-2021) & (K Units)
Table 38. APAC Gaucher Disease Drugs Sales Market Share by Region (2016-2021)
Table 39. APAC Gaucher Disease Drugs Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Gaucher Disease Drugs Revenue Market Share by Region (2016-2021)
Table 41. APAC Gaucher Disease Drugs Sales by Type (2016-2021) & (K Units)
Table 42. APAC Gaucher Disease Drugs Sales Market Share by Type (2016-2021)
Table 43. APAC Gaucher Disease Drugs Sales by Application (2016-2021) & (K Units)
Table 44. APAC Gaucher Disease Drugs Sales Market Share by Application (2016-2021)
Table 45. Europe Gaucher Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 46. Europe Gaucher Disease Drugs Sales Market Share by Country (2016-2021)
Table 47. Europe Gaucher Disease Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Gaucher Disease Drugs Revenue Market Share by Country (2016-2021)
Table 49. Europe Gaucher Disease Drugs Sales by Type (2016-2021) & (K Units)
Table 50. Europe Gaucher Disease Drugs Sales Market Share by Type (2016-2021)
Table 51. Europe Gaucher Disease Drugs Sales by Application (2016-2021) & (K Units)
Table 52. Europe Gaucher Disease Drugs Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Gaucher Disease Drugs Sales by Country (2016-2021) & (K Units)
Table 54. Middle East & Africa Gaucher Disease Drugs Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Gaucher Disease Drugs Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Gaucher Disease Drugs Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Gaucher Disease Drugs Sales by Type (2016-2021) & (K Units)
Table 58. Middle East & Africa Gaucher Disease Drugs Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Gaucher Disease Drugs Sales by Application (2016-2021) & (K Units)
Table 60. Middle East & Africa Gaucher Disease Drugs Sales Market Share by Application (2016-2021)
Table 61. Global Gaucher Disease Drugs Sales Forecast by Type (2021-2026) & (K Units)
Table 62. Global Gaucher Disease Drugs Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Gaucher Disease Drugs Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Gaucher Disease Drugs Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Gaucher Disease Drugs Sales Forecast by Application (2021-2026) & (K Units)
Table 66. Global Gaucher Disease Drugs Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Gaucher Disease Drugs Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Gaucher Disease Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 69. Dong-A-Socio Holdings Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 70. Dong-A-Socio Holdings Gaucher Disease Drugs Product Offered
Table 71. Dong-A-Socio Holdings Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 72. Dong-A-Socio Holdings Main Business
Table 73. Dong-A-Socio Holdings Latest Developments
Table 74. Genzyme Corporation Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Genzyme Corporation Gaucher Disease Drugs Product Offered
Table 76. Genzyme Corporation Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 77. Genzyme Corporation Main Business
Table 78. Genzyme Corporation Latest Developments
Table 79. ExSAR Corporation Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. ExSAR Corporation Gaucher Disease Drugs Product Offered
Table 81. ExSAR Corporation Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 82. ExSAR Corporation Main Business
Table 83. ExSAR Corporation Latest Developments
Table 84. Neuraltus Pharmaceuticals Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Neuraltus Pharmaceuticals Gaucher Disease Drugs Product Offered
Table 86. Neuraltus Pharmaceuticals Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 87. Neuraltus Pharmaceuticals Main Business
Table 88. Neuraltus Pharmaceuticals Latest Developments
Table 89. Amicus Therapeutics Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Amicus Therapeutics Gaucher Disease Drugs Product Offered
Table 91. Amicus Therapeutics Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 92. Amicus Therapeutics Main Business
Table 93. Amicus Therapeutics Latest Developments
Table 94. JCR Pharmaceuticals Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. JCR Pharmaceuticals Gaucher Disease Drugs Product Offered
Table 96. JCR Pharmaceuticals Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 97. JCR Pharmaceuticals Main Business
Table 98. JCR Pharmaceuticals Latest Developments
Table 99. Lixte Biotechnology Holdings Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Lixte Biotechnology Holdings Gaucher Disease Drugs Product Offered
Table 101. Lixte Biotechnology Holdings Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 102. Lixte Biotechnology Holdings Main Business
Table 103. Lixte Biotechnology Holdings Latest Developments
Table 104. Protalix BioTherapeutics Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. Protalix BioTherapeutics Gaucher Disease Drugs Product Offered
Table 106. Protalix BioTherapeutics Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 107. Protalix BioTherapeutics Main Business
Table 108. Protalix BioTherapeutics Latest Developments
Table 109. Greenovation Biotech Basic Information, Gaucher Disease Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Greenovation Biotech Gaucher Disease Drugs Product Offered
Table 111. Greenovation Biotech Gaucher Disease Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 112. Greenovation Biotech Main Business
Table 113. Greenovation Biotech Latest Developments
List of Figures
Figure 1. Picture of Gaucher Disease Drugs
Figure 2. Gaucher Disease Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gaucher Disease Drugs Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Gaucher Disease Drugs Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Gaucher Disease Drugs Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Replace Enzymes
Figure 10. Product Picture of Glucosylceramide Synthase Inhibitors
Figure 11. Product Picture of Osteoporosis Drugs
Figure 12. Global Gaucher Disease Drugs Sales Market Share by Type in 2020
Figure 13. Global Gaucher Disease Drugs Revenue Market Share by Type (2016-2021)
Figure 14. Gaucher Disease Drugs Consumed in Type I Gaucher Disease
Figure 15. Global Gaucher Disease Drugs Market: Type I Gaucher Disease (2016-2021) & (K Units)
Figure 16. Gaucher Disease Drugs Consumed in Type II Gaucher Disease
Figure 17. Global Gaucher Disease Drugs Market: Type II Gaucher Disease (2016-2021) & (K Units)
Figure 18. Gaucher Disease Drugs Consumed in Type III Gaucher Disease
Figure 19. Global Gaucher Disease Drugs Market: Type III Gaucher Disease (2016-2021) & (K Units)
Figure 20. Global Gaucher Disease Drugs Sales Market Share by Application (2016-2021)
Figure 21. Global Gaucher Disease Drugs Revenue Market Share by Application in 2020
Figure 22. Global Gaucher Disease Drugs Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Gaucher Disease Drugs Revenue Market Share by Company in 2020
Figure 24. Global Gaucher Disease Drugs Sales Market Share by Regions (2016-2021)
Figure 25. Global Gaucher Disease Drugs Revenue Market Share by Region in 2020
Figure 26. Americas Gaucher Disease Drugs Sales 2016-2021 (K Units)
Figure 27. Americas Gaucher Disease Drugs Revenue 2016-2021 ($ Millions)
Figure 28. APAC Gaucher Disease Drugs Sales 2016-2021 (K Units)
Figure 29. APAC Gaucher Disease Drugs Revenue 2016-2021 ($ Millions)
Figure 30. Europe Gaucher Disease Drugs Sales 2016-2021 (K Units)
Figure 31. Europe Gaucher Disease Drugs Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Gaucher Disease Drugs Sales 2016-2021 (K Units)
Figure 33. Middle East & Africa Gaucher Disease Drugs Revenue 2016-2021 ($ Millions)
Figure 34. Americas Gaucher Disease Drugs Sales Market Share by Country in 2020
Figure 35. Americas Gaucher Disease Drugs Revenue Market Share by Country in 2020
Figure 36. Americas Gaucher Disease Drugs Sales Market Share by Type in 2020
Figure 37. Americas Gaucher Disease Drugs Sales Market Share by Application in 2020
Figure 38. United States Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Gaucher Disease Drugs Sales Market Share by Region in 2020
Figure 43. APAC Gaucher Disease Drugs Revenue Market Share by Regions in 2020
Figure 44. APAC Gaucher Disease Drugs Sales Market Share by Type in 2020
Figure 45. APAC Gaucher Disease Drugs Sales Market Share by Application in 2020
Figure 46. China Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Gaucher Disease Drugs Sales Market Share by Country in 2020
Figure 53. Europe Gaucher Disease Drugs Revenue Market Share by Country in 2020
Figure 54. Europe Gaucher Disease Drugs Sales Market Share by Type in 2020
Figure 55. Europe Gaucher Disease Drugs Sales Market Share by Application in 2020
Figure 56. Germany Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Gaucher Disease Drugs Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Gaucher Disease Drugs Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Gaucher Disease Drugs Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Gaucher Disease Drugs Sales Market Share by Application in 2020
Figure 65. Egypt Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Gaucher Disease Drugs Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界のゴーシェ病治療薬市場予測 2021年-2026年] (コード:LPI21MY9538)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のゴーシェ病治療薬市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆